癸酰基肉碱通过增强脂肪酸β-氧化改善乙型肝炎病毒感染中的肝脏线粒体功能障碍
本研究通过分析人肝脏公共基因集和小鼠肝脏蛋白质组学,探讨乙型肝炎病毒(HBV)感染相关的代谢紊乱及受累细胞器。体内外实验显示,HBV感染导致脂肪酸β-氧化障碍和线粒体功能障碍,而补充癸酰基肉碱可激活CPT1A表达,改善脂肪酸代谢并修复线粒体功能障碍。小鼠肝脏蛋白质组学提示癸酰基肉碱刺激过氧化物酶体增殖物激活受体(PPAR)信号通路,其中PPARα最为重要。
要点
- HBV感染在体内外均可导致脂肪酸β-氧化障碍和线粒体功能障碍。
- CPT1A过表达可改善肝细胞线粒体功能。
- 补充癸酰基肉碱可激活CPT1A表达,改善脂肪酸代谢并修复线粒体功能障碍。
核心结论
- HBV感染所致的肝细胞脂肪酸代谢受损和线粒体功能障碍可通过外源性补充癸酰基肉碱得到部分恢复。
- 本研究阐明了癸酰基肉碱在HBV感染中的治疗潜力,并为线粒体功能障碍相关疾病提供了新途径。
研究设计与样本
- 分析人肝脏公共基因集,并进行小鼠肝脏蛋白质组学分析,以探索HBV感染相关的代谢紊乱和受累细胞器。
- 在体内和体外研究癸酰基肉碱对脂肪酸β-氧化和线粒体的影响。
- 通过蛋白质组学分析展示涉及的信号通路,并用蛋白质印迹(Western blot)确认。
主要发现
- HBV感染在体内和体外均可导致脂肪酸β-氧化障碍和线粒体功能障碍。
- CPT1A过表达可改善肝细胞线粒体功能。
- 补充癸酰基肉碱可激活CPT1A表达,从而改善脂肪酸代谢并修复线粒体功能障碍。
- 小鼠肝脏蛋白质组学分析提示癸酰基肉碱刺激过氧化物酶体增殖物激活受体(PPAR)信号通路,且PPARα是PPARs中最重要的。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of metabolic-associated steatotic liver disease in patients with chronic hepatitis B is increasing annually; however, the interaction between hepatitis B virus (HBV) infection and lipid metabolism remains unclear. This study attempted to clarify whether fatty acid metabolism regulation could alleviate mitochondrial dysfunction caused by HBV infection. METHODS: A public gene set of human livers was analyzed, and a proteomic analysis on mouse livers was conducted to explore metabolic disorders and affected organelles associated with HBV infection. The effect of decanoylcarnitine on fatty acid β-oxidation and mitochondria was investigated in vivo and in vitro. The pathways involved were shown by proteomic analysis and confirmed by Western blot. RESULTS: HBV infection could cause fatty acid β-oxidation disorder and mitochondrial dysfunction in vivo and in vitro. CPT1A overexpression could improve mitochondrial function in hepatocytes. Furthermore, decanoylcarnitine supplementation could activate CPT1A expression, thus improving fatty acid metabolism and repairing mitochondrial dysfunction. Proteomic analysis of mouse livers suggests that decanoylcarnitine stimulates the peroxisome proliferator-activated receptor (PPAR) signaling pathway, and PPARα was the most important among PPARs. CONCLUSIONS: Impaired fatty acid metabolism and mitochondrial dysfunction in hepatocytes caused by HBV infection could be partially restored by exogenous supplementation of decanoylcarnitine. This work elucidates the therapeutic potential of decanoylcarnitine in HBV infection and provides a new approach for diseases related to mitochondrial dysfunction.
引用
- Sun Y, Chen Q, Liu Y, et al. Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation. J Infect Dis. 2025. PMID: 39774664. doi:10.1093/infdis/jiaf014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。